Management of Hepatitis C Infection with Direct Action Antiviral Drugs (DAA)**
<p>Several new direct action antiviral drugs (DAA) against the HCV virus (HCV) are approved and marketed. The combination of DAA with pegylated interferon and ribavirin (PR) is only recommended to patients with tolerance to interferon (IFN). IFN-free treatments are now considered elective drug...
Saved in:
Main Authors: | , , , |
---|---|
格式: | 图书 |
出版: |
Archives of Hepatitis Research - Peertechz Publications,
2015-12-30.
|
主题: | |
在线阅读: | Connect to this object online. |
标签: |
添加标签
没有标签, 成为第一个标记此记录!
|
因特网
Connect to this object online.3rd Floor Main Library
索引号: |
A1234.567 |
---|---|
复印件 1 | 可用 |